Mohawk Industries Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw adjusted EPS rise 25% year-over-year to $1.90, with net sales up 8% as reported. Price increases and productivity gains offset inflation, but ongoing volatility from the Middle East conflict and rising input costs are expected to impact results in the second half.
Fiscal Year 2025
-
Q4 sales rose 2.4% as reported, with adjusted EPS up 3% year-over-year, while full-year sales were flat and adjusted EPS fell 7.5%. 2026 guidance anticipates improved sales and earnings, supported by restructuring, productivity, and pricing actions, though risks from inflation and market uncertainty remain.
-
Q3 2025 sales rose 1.4% to $2.8B, with adjusted EPS at $2.67, driven by premium and commercial products. Restructuring and productivity initiatives are expected to deliver $110M in annual savings, while tariffs and input costs remain headwinds. Q4 EPS is guided at $1.90–$2.00.
-
Q2 sales were flat at $2.8B with adjusted EPS of $2.77, supported by productivity and restructuring, while input costs and market softness persisted. Guidance for Q3 EPS is $2.56–$2.66, with improvement expected in Q4 as inflation eases and restructuring benefits accrue.
-
Q1 sales declined 5.7% to $2.5B, with adjusted EPS at $1.52, supported by productivity gains and restructuring. Tariffs are expected to add $50M in annual costs, to be offset by price increases and supply chain actions. Q2 adjusted EPS is guided at $2.52–$2.62.
Fiscal Year 2024
-
Q4 and full-year results were resilient despite ongoing market softness, with stable sales and adjusted EPS, strong free cash flow, and continued restructuring progress. Guidance anticipates Q1 2025 headwinds from system issues and inflation, but expects normal seasonality and incremental cost savings.
-
Q3 saw adjusted EPS rise 7% to $2.90 despite a 2% sales decline, driven by productivity and cost actions. Q4 guidance is for adjusted EPS of $1.77–$1.87, with hurricane impacts expected but recovery anticipated in 2025 as rates fall and demand rebounds.
-
Q2 2024 saw sales decline 5.1% year-over-year to $2.8B, but adjusted EPS rose 9% to $3, driven by productivity and restructuring. Ongoing cost actions and share buybacks support strong cash flow, while management expects continued market softness and pricing pressure in Q3.